📰 Dexcom News
Page 91 - Dexcom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dexcom. Real-time updates on events, politics, business and more.
December 23, 2023
DexCom (NASDAQ:DXCM – Free Report) had its target price increased by Piper Sandler from $135.00 to $150.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical device company’s stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus […]
December 22, 2023
Courier Capital LLC cut its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,392 shares of the medical device company’s stock after selling 257 shares during the quarter. […]
December 22, 2023
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) traded down 4.9% during trading on Wednesday . The stock traded as low as $115.64 and last traded at $117.29. 758,423 shares were traded during mid-day trading, a decline of 77% from the average session volume of 3,354,984 shares. The stock had previously closed at $123.29. Analysts Set […]
December 21, 2023
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund bought 14,738 shares of the medical device company’s stock, valued at approximately $1,375,000. Other hedge funds and other institutional investors also recently made changes to their positions in the […]
December 20, 2023
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
December 18, 2023
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in […]
December 13, 2023
Prosperity Financial Group Inc. raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 2,335 shares of the medical device company’s stock after purchasing an additional 145 shares during the period. Prosperity Financial Group Inc.’s […]
December 12, 2023
Holocene Advisors LP lifted its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,604,553 shares of the medical device company’s stock after acquiring an additional 93,377 shares during the period. […]
December 12, 2023
Point72 Europe London LLP purchased a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 19,540 shares of the medical device company’s stock, valued at approximately $2,511,000. Other institutional investors have also added […]
December 8, 2023
DexCom (NASDAQ:DXCM – Free Report) had its price objective upped by Morgan Stanley from $101.00 to $122.00 in a report published on Monday morning, Benzinga reports. They currently have an equal weight rating on the medical device company’s stock. DXCM has been the topic of several other reports. Leerink Partnrs reaffirmed an outperform rating on […]